MarketInOut Stock Screener Log In | Sign Up

Caplin Point Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 09:59
Caplin Point Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization169,054 mln
Float20.31 mln

EPS

87.28
Exceptional

P / E

27.18
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.99
Caution advised

Relative Strength

76 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

Business Description

Founded in 1990 and based in Chennai, India, Caplin Point Laboratories develops, manufactures, and sells a wide range of generic and branded medicines for both domestic and international markets. The company's product portfolio spans nearly every major dosage form, including tablets, capsules, injectable solutions, eye drops, creams, inhalers, and intravenous infusions, among many others.

Key Fundamentals

EPS87.28
P/E27.18
ROE20.80
RPS301
ROIC24.37
ROA18.55
Interest Cover816
EBITDA, mln9,225
EV / EBITDA21.69
EV / EBIT23.69
Revenue, mln22,873
EV / Revenue8.75

Quote Details

Last 2,357.95
Change 16.95 (0.72%)
Open 2,363.65
Volume 1,217
Turnover 2,869,625
Average Volume 8,772.76

Financial Ratios

Pre-Tax Profit Margin37
Leverage Ratio1.13
Current Ratio6.70
Price / Book5.79
Price / Tangible Book5.88
Price / Cash Flow66.31
Price / Free Cash Flow63.48
Debt / Equity0.00
Price / Sales9.02
PEG Ratio1.54

Financial Strength

Altman Z-Score33.1
Piotroski F-Score 6 / 9
Beneish M-Score-1.99
Price to Intrinsic Value3.56
Price to Lynch Fair Value1.56
Price to Graham Number2.90
Shiller PE Ratio53.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.26% 92 / 100   
1 Month -16.33% 15 / 100   
2 Months -9.73% 46 / 100   
6 Months 34.45% 88 / 100   
1 Year 19.45% 81 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog